Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Tissue microarrays for testing basal biomarkers in familial breast cancer cases
Publication

Publications

Tissue microarrays for testing basal biomarkers in familial breast cancer cases

Title
Tissue microarrays for testing basal biomarkers in familial breast cancer cases
Type
Article in International Scientific Journal
Year
2007
Authors
Dufloth, RM
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Matos, I
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Fernando Schmitt
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Zeferino, LC
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Vol. 125
Pages: 226-230
ISSN: 1516-3180
Other information
Authenticus ID: P-004-8WD
Abstract (EN): CONTEXT AND OBJECTIVE: The proteins p63, p-cadherin and CK5 are consistently expressed by the basal and myoepithelial cells of the breast, although their expression in sporadic and familial breast cancer cases has yet to be fully defined. The aim here was to study the basal immunoprofile of a breast cancer case series using tissue microarrary technology. DESIGN AND SETTING: This was a cross-sectional study at Universidade Estodual de Compinas, Brazil, and the Institute of Pathology and Molecular Immunology, Porto, Portugal. METHODS: Immunohistochemistry using the antibodies l CK5 and p-cadherin, and also estrogen receptor (ER) and Human Epidermal Receptor Growth Factor 2 (HER2), was performed on 168 samples from a breast cancer case series. The criteria for identifying women at high risk were based on those of the Breast Cancer Linkage Consortium. RESULTS: Familial tumors were more frequently positive for the p-cadherin (p = 0.0004), p63 (p < 0.0001) and CK5 (p < 0.0001) than was sporadic cancer. Moreover, familial tumors had coexpression of the basal biomarkers CK5+/p63+, grouped two by two (OR = 34.34), while absence of coexpression (OR = 0.13) was associated with the sporadic cancer phenotype. CONCLUSION: Familial breast cancer was found to be associated with basal biomarkers, using tissue microarray technology. Therefore, characterization of the familial breast cancer phenotype will improve the understanding of breast carcinogenesis.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 5
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

Sydenham's chorea in a family with Huntington's disease: case report and review of the literature (2011)
Another Publication in an International Scientific Journal
Santos Silva, R; Corujeira, S; Almeida, AF; Granja, S; Moura, C; Inês Azevedo; Leao, M; Maia, A
Loci identified through genome-wide association studies and lung cancer risk: is there anything more? (2013)
Another Publication in an International Scientific Journal
De Mello, RA; Araujo, A; Hespanhol V; Reis, RM
Indolent systemic mastocytosis limited to the bone: a case report and review of the literature (2013)
Another Publication in an International Scientific Journal
Pinto Lopes, P; Fonseca, FA; Silva, R; von Hafe P; Fonseca, E
Renal failure due to primary amyloidosis: a case report and literature review. (2011)
Article in International Scientific Journal
Ramon Andrade de Mello; Dania Sofia Marques Santos; Margarida Freitas-Silva; Joaquim Andrade

See all (10)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-20 at 21:49:18 | Privacy Policy | Personal Data Protection Policy | Whistleblowing